Literature DB >> 20587646

Essential covalent linkage between the chymotrypsin-like domain and the extra domain of the SARS-CoV main protease.

Meng-Ying Tsai1, Wei-Hsin Chang, Jin-Yi Liang, Long-Liu Lin, Gu-Gang Chang, Hui-Ping Chang.   

Abstract

The main protease of the coronavirus causing severe acute respiratory syndrome performs proteolytic processing of the viral polyproteins. The active form of the enzyme is a homodimer with each subunit consisting of three structural domains. Domains I and II, hosting the complete catalytic machinery, constitute the N-terminal chymotrypsin-like folding scaffold and connect to the extra C-terminal domain III by a long loop. Previously, the domain III-truncated enzyme was demonstrated to fold independently into an intact chymotrypsin-like fold, but it showed no enzyme activity. To further delineate the structure-function relationships of the domain III and the long loop, we generated some truncated and mutated M(pro) forms bearing various combinations of the loop with other structural parts of the enzyme. Their conformational and association properties were investigated in detail. Far-ultraviolet circular dichroism (CD) measurements revealed that these fragments could fold independently. The secondary, tertiary and quaternary structures of these mixtures were monitored by CD, fluorescence spectroscopy and analytical ultracentrifugation. However, no enzyme activity was observed for any mutant or mixtures. These observations indicate that the covalent linkage between the chymotrypsin like and the extra domain is essential for enzymatic activity of the main coronavirus protease and for the integrity of its quaternary structure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20587646     DOI: 10.1093/jb/mvq071

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  5 in total

1.  Structures of the Middle East respiratory syndrome coronavirus 3C-like protease reveal insights into substrate specificity.

Authors:  Danielle Needle; George T Lountos; David S Waugh
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2015-04-24

2.  Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design.

Authors:  Maria Bzówka; Karolina Mitusińska; Agata Raczyńska; Aleksandra Samol; Jack A Tuszyński; Artur Góra
Journal:  Int J Mol Sci       Date:  2020-04-28       Impact factor: 5.923

3.  X-ray crystallographic characterization of the SARS-CoV-2 main protease polyprotein cleavage sites essential for viral processing and maturation.

Authors:  Jaeyong Lee; Calem Kenward; Liam J Worrall; Marija Vuckovic; Francesco Gentile; Anh-Tien Ton; Myles Ng; Artem Cherkasov; Natalie C J Strynadka; Mark Paetzel
Journal:  Nat Commun       Date:  2022-09-03       Impact factor: 17.694

4.  Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates.

Authors:  Mateus S M Serafim; Jadson C Gertrudes; Débora M A Costa; Patricia R Oliveira; Vinicius G Maltarollo; Kathia M Honorio
Journal:  Biosci Rep       Date:  2021-03-26       Impact factor: 3.840

Review 5.  Structure-Function Characteristics of SARS-CoV-2 Proteases and Their Potential Inhibitors from Microbial Sources.

Authors:  Rafida Razali; Haslina Asis; Cahyo Budiman
Journal:  Microorganisms       Date:  2021-11-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.